Erik’s primary research focus includes exercise testing and training in clinical populations, with an emphasis in prostate cancer. He is interested in the role of exercise to improve skeletal muscle function during anti-cancer therapies. He also examines how the immune system responds to acute and chronic exercise during cancer treatment, both as a potential therapy and means of reducing disease recurrence. He is currently a member of the Cancer Prevention and Control group within the Lineberger Comprehensive Cancer Center, as well as the American College of Sports Medicine and the International Society of Exercise Immunology.